Six new consultations have opened for comments on the GMMMG website. Including consultations opened yesterday, the following are now accepting comments.
To take part in these or any other consultations, visit https://gmmmg.nhs.uk/consultations/.
- Commissioning statement: shower protection pouches / vascular access protection (VAP) dressings
- Primary immune thrombocytopenia (ITP) in adults treatment pathway
- CRG actions – July 2026
- Sotatercept for pulmonary arterial hypertension – RED
- Nusinersen and risdiplam for spinal muscular atrophy – RED
- Mepolizumab for COPD – RED
- Seladelpar for primary biliary cholangitis – RED
- Atogepant for treating migraine – GREEN
These consultations will run for six weeks and close at 5pm on Thursday 10th or Friday 11th September. Please see individual consultations for detail.
Shared care
There are five ongoing consultations relating to shared care for medicines:
- Shared care for undocumented patients and shared care for medicines principles
- Shared care protocol: guanfacine for children and adolescents
- Shared care protocol: sulfasalazine for patients in paediatric services
- Shared care protocol: azathioprine for patients in paediatric services
- Shared care protocol: domperidone for GORD for patients in paediatric services
These consultations will run for six weeks and close at 5pm on Thursday 10th or Friday 11th September. Please see individual consultations for detail.
7-minute briefings
Two 7-minute briefings have been developed by the Medicines Safety Subroup:
- Learning from a Medication Incident: Rivastigmine Patches
- Learning from a Methotrexate-Related Death: Preventing Future Harm
These consultations will run for two weeks and close at 5pm on Friday 14th August
To take part in these or any other consultations, visit https://gmmmg.nhs.uk/consultations/.